Investors Overview

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the U.S., and South America. Cipher is focused on building strategic sales and distribution partnerships, out licensing products and selective investments in drug development to assemble a broad portfolio of prescription products that serve unmet medical needs. 

Annual Reports

2017 Annual Report

Financial Reports

Quarterly Reports

Presentations

Events & Webcasts

View a listing of our recent events and webcasts

Thursday, November 7, 2019
8:30am EST

DIAL IN NUMBER: (416) 764-8609 or (888) 390-0605
CONFERENCE ID: 55559849
REPLAY: (416) 764-8677 or (888) 390-0541 (playback code 559849 #)
Available until midnight (ET) Thursday, November 14, 2019